source · text/markdown
source_afe84ed391b34585
sha256 b5a4166fc8fc0a4897327ca92ec412a050ea083783b305f1311b81831bc59e67
by researka:v2 · 2026-05-26 17:19:07.205860+04:00
# Alpha memo — exercise **Headline:** Pathway-specific anti-inflammatory gating: metformin unlocks TNF-axis suppression in exercise-responsive cancer survivors that exercise alone cannot achieve **Alpha triage:** `high` (internal ranking; not a certainty claim) **Confidence:** `evidence_backed_signal` **Memo surface:** `alpha memo` **Snapshot:** `2026-05-16T18-12-38Z` **Run:** `exercise-evidence-2026-05-16T18-12-38Z` **Source breadth:** `5/5` unique cited source(s) ## One-sentence thesis The cited A/B receipts support a specific working claim: Compared with control, exercise alone reduced hs-CRP [-30.2%; 95% CI, -50.3, -1.0]; exercise alone reduced hs-CRP and IL6 (-30.9%; 95% CI, -47.3, -9.5). ## Why this is surprising The useful signal is narrower than the topic label: the lead receipts support the core claim, while the added A/B context receipts define where that claim may generalize, fail, or need a separate extraction. ## Evidence receipts - `fact_id=22116` (`A_core`) — Compared with control, exercise alone reduced hs-CRP [-30.2%; 95% CI, -50.3, -1.0] DOI `10.1158/1940-6207.capr-20-0188` - `fact_id=22117` (`A_core`) — exercise alone reduced hs-CRP and IL6 (-30.9%; 95% CI, -47.3, -9.5) DOI `10.1158/1940-6207.capr-20-0188` - `fact_id=22118` (`A_core`) — exercise and metformin reduced sTNFαR2 and IL6 (-38.7%; 95% CI, -52.3, -18.9) DOI `10.1158/1940-6207.capr-20-0188` - `fact_id=22119` (`A_core`) — exercise and metformin reduced sTNFαR2 (-13.1%; 95% CI, -22.9, -1.0) DOI `10.1158/1940-6207.capr-20-0188` ## Context receipts - `fact_id=12572` (`A_core`) — Mixed-muscle protein fractional synthetic rate increased by 42% at 3 h postexercise and 69% at 24 h postexercise in CON. DOI `10.1152/ajpendo.00600.2013` - `fact_id=41245` (`A_core`) — tumor-bearing mice with access to running wheels showed reduced growth of MDA-MB-231 (-66%, P < 0.01) tumors DOI `10.1158/0008-5472.can-16-3125` - `fact_id=12544` (`A_core`) — Mortality risk was 11% lower (hazard ratio, 0.89; 95% confidence interval, 0.86-0.93; P<0.001) for every 1-MET increase in exercise capacity. DOI `10.1161/hypertensionaha.114.03510` - `fact_id=30392` (`A_core`) — IGF-I/IGFBP-3 ratio increased significantly in the diet + exercise group (+5.4%, P < 0.01) compared with control. DOI `10.1158/1055-9965.epi-13-0337` ## What this changes Treat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and next extraction that could confirm or kill the thesis. ## Limitations - This is an alpha memo, not a settled review, guideline, or broad consensus claim. - This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review. - Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below. - Independent receipts fail to reproduce the claimed contrast. - The effect depends on one protocol, subgroup, comparator, or extraction artifact. ## What would weaken this - Independent receipts fail to reproduce the claimed contrast. - The effect depends on one protocol, subgroup, comparator, or extraction artifact. ## Strongest counter-evidence - _No A_core/B_context counter-evidence found in this run; treat this as a single-direction signal until a broader receipt expansion finds a real opposing fact._ ## Next extraction - Extract independent A_core/B_context receipts that test the lead contrast directly. - Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method. - Run a follow-up pass that either connects each context receipt to the lead claim or splits it into a separate memo. ## Provenance / priority - **Topic:** `exercise` - **Author:** Dom Lynch - **ORCID:** _not configured_ - **Version:** 1.0 - **License:** CC BY-NC 4.0 - **Canonical URL:** _not assigned_ - **Suggested citation:** Dom Lynch. (2026). Pathway-specific anti-inflammatory gating: metformin unlocks TNF-axis suppression in exercise-responsive cancer survivors that exercise alone cannot achieve. ReseaRka Evidence Index. Version 1.0. - **Run bundle SHA-256:** `fe487b28cd8297287f8c8def5605a5aac25b0a1723c07436f22dfdaea7dc6374` - **Memo SHA-256:** `2e3c1bb4c7c9af4d604c9ab9be59c1ff2fbfb548640cd201df4c966e25ea3b5d` - **Priority note:** This memo records the first published framing, source bundle, and evidence receipts for this run. Reuse should cite the canonical version.
metadata
{
"article_type": "alpha_memo",
"domain_slug": "general",
"researka_object_type": "submission",
"researka_submission_id": "a259f4a1-c137-42b5-8298-41d41a37d3c0",
"title": "Pathway-specific anti-inflammatory gating: metformin unlocks TNF-axis suppression in exercise-responsive cancer survivors that exercise alone cannot achieve"
}